Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 722       

    Article Cited by others

EDITORIAL

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?

Sharma Surendra K, Dheda Keertan

Year : 2019| Volume: 149| Issue : 3 | Page no: 309-312

   This article has been cited by
 
1 Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Jessica Carter,Jon S. Friedland,Daniela E. Kirwan,Ruvandhi R. Nathavitharana
ERJ Open Research. 2020; 6(4): 00562-2020
[Pubmed]  [Google Scholar] [DOI]
2 Evolution of newer regimens in TB from RNTCP to NTEP
Aditi Gupta,Vishal Chopra
Indian Journal of Tuberculosis. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin
Paige M. E. Hawkins,Wendy Tran,Gayathri Nagalingam,Chen-Yi Cheung,Andrew M. Giltrap,Gregory M. Cook,Warwick J. Britton,Richard J. Payne
Chemistry – A European Journal. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 First case report in Latin America: Oral treatment of multidrug-resistant tuberculosis with delamanid and bedaquiline in combination with linezolid, moxifloxacin and clofazimine following a DRESS syndrome in a peruvian patient
S. Pecho-Silva,A.C. Navarro-Solsol
Pulmonology. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Tuberculosis in childhood and adolescence: a view from different perspectives
Tony T. Tahan,Betina M.A. Gabardo,Andrea M.O. Rossoni
Jornal de Pediatria (Versão em Português). 2020; 96: 99
[Pubmed]  [Google Scholar] [DOI]
6 Tuberculosis treatment in children: the changing landscape
Julie Huynh,Guy Thwaites,Ben J Marais,H Simon Schaaf
Paediatric Respiratory Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
Simone HJ van den Elsen,Marieke GG Sturkenboom,Onno Akkerman,Linda Barkane,Judith Bruchfeld,Geoffrey Eather,Scott K Heysell,Henadz Hurevich,Liga Kuksa,Heinke Kunst,Johanna Kuhlin,Katerina Manika,Charalampos Moschos,Stellah G Mpagama,Marcela Muñoz Torrico,Alena Skrahina,Giovanni Sotgiu,Marina Tadolini,Simon Tiberi,Francesca Volpato,Tjip S van der Werf,Malcolm R Wilson,Joaquin Zúñiga,Daan J Touw,Giovanni B Migliori,Jan-Willem Alffenaar
BMJ Open. 2020; 10(6): e035350
[Pubmed]  [Google Scholar] [DOI]
8 Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study
Mengqiu Gao,Jingtao Gao,Li Xie,Guihui Wu,Wei Chen,Yu Chen,Yi Pei,Guobao Li,Yuhong Liu,Wei Shu,Lin Fan,Qianhong Wu,Juan Du,Xiaohong Chen,Peijun Tang,Yu Xiong,Mingwu Li,Qingshan Cai,Long Jin,Zaoxian Mei,Yu Pang,Liang Li
Clinical Microbiology and Infection. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Correspondence regarding “Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa”
Erika Mohr-Holland,Anja Reuter,Jennifer Hughes,Johnny Daniels,Busisiwe Beko,Goodman Makhanda,Virginia De Avezedo,Yulene Kock,Helen Cox,Jennifer Furin,Laura Trivino Duran,Petros Isaakidis,Gabriella Ferlazzo
European Respiratory Journal. 2020; 56(1): 2000837
[Pubmed]  [Google Scholar] [DOI]
10 Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999–2018)
Hendrik S Camphor,Kerri Viney,Ben Polkinghorne,Kate Pennington
Communicable Diseases Intelligence. 2020; 44
[Pubmed]  [Google Scholar] [DOI]
11 Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
Samiksha Ghimire,Samriddhi Karki,Bhagwan Maharjan,Jos G W Kosterink,Daan J Touw,Tjip S van der Werf,Bhabana Shrestha,Jan-Willem Alffenaar
BMJ Open Respiratory Research. 2020; 7(1): e000606
[Pubmed]  [Google Scholar] [DOI]
12 Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: A systematic review and meta-analysis
Dumessa Edessa,Mekonnen Sisay,Yadeta Dessie,Qigui Yu
PLOS ONE. 2020; 15(8): e0237534
[Pubmed]  [Google Scholar] [DOI]
13 Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo
Michel Kaswa Kayomo,Vital Nkake Mbula,Muriel Aloni,Emmanuel André,Leen Rigouts,Fairouz Boutachkourt,Bouke C. de Jong,Nicolas M. Nkiere,Anna S. Dean
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
14 Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
Anna S. Dean,Matteo Zignol,Andrea Maurizio Cabibbe,Dennis Falzon,Philippe Glaziou,Daniela Maria Cirillo,Claudio U. Köser,Lice Y. Gonzalez-Angulo,Olga Tosas-Auget,Nazir Ismail,Sabira Tahseen,Maria Cecilia G. Ama,Alena Skrahina,Natavan Alikhanova,S. M. Mostofa Kamal,Katherine Floyd,Madhukar Pai
PLOS Medicine. 2020; 17(1): e1003008
[Pubmed]  [Google Scholar] [DOI]
15 Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens: a systematic review
Emmanuel Rivière,Michael G. Whitfield,Jochem Nelen,Tim H. Heupink,Annelies Van Rie
Clinical Microbiology and Infection. 2020;
[Pubmed]  [Google Scholar] [DOI]
16 Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
Jonathon R. Campbell,Dennis Falzon,Fuad Mirzayev,Ernesto Jaramillo,Giovanni Battista Migliori,Carole D. Mitnick,Norbert Ndjeka,Dick Menzies
Emerging Infectious Diseases. 2020; 26(3)
[Pubmed]  [Google Scholar] [DOI]
17 What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SurendraK Sharma,Keertan Dheda
Indian Journal of Medical Research. 2019; 149(3): 309
[Pubmed]  [Google Scholar] [DOI]
18 A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis
Karen Cohen,Gary Maartens
Expert Opinion on Drug Safety. 2019;
[Pubmed]  [Google Scholar] [DOI]
19 Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe,Tabassum Khan,Chintan Bhavsar,Munira Momin,Abdelwahab Omri
Expert Opinion on Drug Delivery. 2019; 16(5): 525
[Pubmed]  [Google Scholar] [DOI]
20 Drug-resistant tuberculosis: Progress towards shorter and safer regimens
Kavitha Saravu,Madhukar Pai
Lung India. 2019; 36(5): 373
[Pubmed]  [Google Scholar] [DOI]

 

Read this article